Abstract
Some forms of peripheral autonomic dysfunction (especially enteric neuropathy and subacute panautonomic failure) occur as autoimmune phenomena either in isolation or in the context of cancer. Autoimmune autonomic ganglionopathy is an example of a severe, but potentially treatable, antibody-mediated form of autonomic failure. Diagnostic evaluation of autonomic disorders can be supplemented by testing for paraneoplastic antibodies and antibodies against membrane receptors. The diagnostic antibodies most commonly associated with dysautonomia are paraneoplastic antibodies (anti-Hu and CRMP-5) and ganglionic acetylcholine receptor antibodies.
Similar content being viewed by others
References
Candler PM, Hart PE, Barnett M, Weil R, Rees JH (2004) A follow up study of patients with paraneoplastic neurological disease in the United Kingdom. J Neurol Neurosurg Psychiatry 75:1411–1415
Chinn JS, Schuffler MD (1988) Paraneoplastic visceral neuropathy as a cause of severe gastrointestinal motor dysfunction. Gastroenterology 95:1279–1286
Darnell RB (2004) Paraneoplastic neurologic disorders: windows into neuronal function and tumor immunity. Arch Neurol 61:30–32
Font J, Ramos-Casals M, de la Red G, Pou A, Casanova A, Garcia-Carrasco M, Cervera R, Molina JA, Valls J, Bove A, Ingelmo M, Graus F (2003) Pure sensory neuropathy in primary Sjogren’s syndrome. Longterm prospective followup and review of the literature. J Rheumatol 30:1552–1557
Goldstein D, Holmes C, Dendi R, Li S-T, Brentzel S, Vernino S (2002) Pandysautonomia associated with impaired ganglionic neurotransmission and circulating antibody to the neuronal nicotinic receptor. Clin Auton Res 12:281–285
Graus F, Lang B, Pozo-Rosich P, Saiz A, Casamitjana R, Vincent A (2002) P/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology 59:764–766
Hart IK, Maddison P, Newsom-Davis J, Vincent A, Mills KR (2002) Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain 125:1887–1895
Hart RG, Kanter MC (1990) Acute autonomic neuropathy. Two cases and a clinical review. Arch Intern Med 150:2373–2376
Honnorat J, Byk T, Kusters I, Aguera M, Ricard D, Rogemond V, Quach T, Aunis D, Sobel A, Mattei MG, Kolattukudy P, Belin MF, Antoine JC (1999) Ulip/CRMP proteins are recognized by autoantibodies in paraneoplastic neurological syndromes. Eur J Neurosci 11:4226–4232
Josephs KA, Silber MH, Fealey RD, Nippoldt TB, Auger RG, Vernino S (2004) Neurophysiologic studies in Morvan syndrome. J Clin Neurophysiol 21:440–445
Jun S, Dimyan M, Jones KD, Ladabaum U (2005) Obstipation as a paraneoplastic presentation of small cell lung cancer: case report and literature review. Neurogastroenterol Motil 17:16–22
Klein CM, Vernino S, Lennon VA, Sandroni P, Fealey RD, Benrud-Larson L, Sletten D, Low PA (2003) The spectrum of autoimmune autonomic neuropathies. Ann Neurol 53:752–758
Knowles CH, Lang B, Clover L, Scott SM, Gotti C, Vincent A, Martin JE (2002) A role for autoantibodies in some cases of acquired non-paraneoplastic gut dysmotility. Scand J Gastroenterol 37:166–170
Lambert EH, Lennon VA (1988) Selected IgG rapidly induces Lambert-Eaton myasthenic syndrome in mice: complement independence and EMG abnormalities. Muscle Nerve 11:1133–1145
Lawn ND, Westmoreland BF, Kiely MJ, Lennon VA, Vernino S (2003) Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc 78:1363–1368
Lee EK, Maselli RA, Ellis WG, Agius MA (1998) Morvan’s fibrillary chorea: a paraneoplastic manifestation of thymoma. J Neurol Neurosurg Psychiatry 65:857–862
Liguori R, Vincent A, Clover L, Avoni P, Plazzi G, Cortelli P, Baruzzi A, Carey T, Gambetti P, Lugaresi E, Montagna P (2001) Morvan’s syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 124:2417–2426
Liu W, Fackler W, Rice TW, Richter JE, Achkar E, Goldblum JR (2002) The pathogenesis of pseudoachalasia: a clinicopathologic study of 13 cases of a rare entity. Am J Surg Pathol 26:784–788
Lucchinetti CF, Camilleri M, Lennon VA (1994) Gastrointestinal dysmotility spectrum in patients seropositive for paraneoplastic type 1 anti-neuronal nuclear autoantibodies. Clin Auton Res 4:206
Lucchinetti CF, Kimmel DW, Lennon VA (1998) Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology 50:652–657
Naito Y, Matsumoto I, Wakamatsu E, Goto D, Sugiyama T, Matsumura R, Ito S, Tsutsumi A, Sumida T (2005) Muscarinic acetylcholine receptor autoantibodies in patients with Sjogren’s syndrome. Ann Rheum Dis 64:510–511
Newsom-Davis J, Mills KR (1993) Immunological associations of acquired neuromyotonia (Isaacs’ syndrome) Report of five cases and literature review. Brain 116:453–469
O’Neill JH, Murray NM, Newsom-Davis J (1988) The Lambert-Eaton myasthenic syndrome. A review of 50 cases. Brain 111:577–596
Pittock SJ, Kryzer TJ, Lennon VA (2004) Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol 56:715–719
Rakocevic G, Barohn R, McVey AL, Damjanov I, Vernino S, Lennon V (2003) Myasthenia gravis, thymoma, and intestinal pseudo-obstruction: a case report and review. J Clin Neuromusc Dis 5:93–95
Shillito P, Molenaar PC, Vincent A, Leys K, Zheng W, Berg RJvd, Plomp JJ, Kempen GTHV, Chauplannaz G, Wintzen AR, Dijk JGv, Newsom-Davis J (1995) Acquired neuromyotonia: evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol 38:714–722
Sillevis Smitt PA, Manley GT, Posner JB (1995) Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice. Neurology 45:1873–1878
Suarez GA, Fealey RD, Camilleri M, Low PA (1994) Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology 44:1675–1682
Thieben M, Sandroni P, Benrud-Larson L, Fealey R, Vernino S, Lennon V, Low P (2007) Postural Orthostatic Tachycardia Syndrome—Mayo Clinic Experience. Mayo Clin Proc
Vernino S, Adamski J, Kryzer TJ, Fealey RD, Lennon VA (1998) Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology 50:1806–1813
Vernino S, Ermilov LG, Sha L, Szurszewski JH, Low PA, Lennon VA (2004) Passive transfer of autoimmune autonomic neuropathy to mice. J Neurosci 24:7037–7042
Vernino S, Kryzer T, Lennon V (2002) Autoantibodies in autoimmune autonomic neuropathies and neuromuscular hyperexcitability disorders. In: Rose N, Hamilton R, Detrick B (eds) Manual of clinical laboratory immunology. ASM Press, Washington, DC, pp 1013–1017
Vernino S, Lennon VA (2004) Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res 10:7270–7275
Vernino S, Lennon VA (2002) Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability. Muscle Nerve 26:702–707
Vernino S, Lindstrom J, Hopkins S, Wang Z, Low PA (2008) Characterization of ganglionic acetylcholine receptor autoantibodies. J Neuroimmunol 197:63–69
Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA (2000) Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 343:847–855
Vernino S, Wolfe GI (2007) Antibody testing in peripheral neuropathies. Neurol Clin 25:29–46
Viallard J-F, Vincent A, Moreau J-F, Parrens M, Pellegrin J-L, Ellie E (2005) Thymoma-associated neuromyotonia with antibodies against voltage-gated potassium channels presenting as chronic intestinal pseudo-obstruction. Eur Neurol 53:60–63
Vincent A (2002) Unravelling the pathogenesis of myasthenia gravis. Nature Rev Immunol 2:797–804
Vincent A, Lang B, Newsom-Davis J (1989) Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder. Trends Neurosci 12:496–502
Voltz R, Carpentier AF, Rosenfeld MR, Posner JB, Dalmau J (1999) P/Q-type voltage-gated calcium channel antibodies in paraneoplastic disorders of the central nervous system. Muscle Nerve 22:119–122
Wang Z, Low PA, Jordan J, Freeman R, Gibbons CH, Schroeder C, Sandroni P, Vernino S (2007) Autoimmune autonomic ganglionopathy: IgG effects on ganglionic acetylcholine receptor current. Neurology 68:1917–1921
Younes-Mhenni S, Janier MF, Cinotti L, Antoine JC, Tronc F, Cottin V, Ternamian PJ, Trouillas P, Honnorat J (2004) FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes. Brain 127:2331–2338
Young R, Asbury A, Adams R, Corbett J (1969) Pure pandysautonomia with recovery. Trans Am Neurol Assoc 94:355–357
Young RR, Asbury AK, Corbett JL, Adams RD (1975) Pure pan-dysautonomia with recovery. Brain 98:613–636
Yu Z, Kryzer TJ, Griesmann GE, Kim K, Benarroch EE, Lennon VA (2001) CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity. Ann Neurol 49:146–154
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vernino, S. Antibody testing as a diagnostic tool in autonomic disorders. Clin Auton Res 19, 13–19 (2009). https://doi.org/10.1007/s10286-008-0488-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10286-008-0488-6